These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 22427774)
1. Interleukin-18 expression and the response to treatment in patients with psoriasis. Mohamed Attia HR; Mikhael N; Ismail S Arch Med Sci; 2010 Dec; 6(6):964-70. PubMed ID: 22427774 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-18 expression and the response to treatment in patients with psoriasis. Rasmy H; Mikhael N; Ismail S Arch Med Sci; 2011 Aug; 7(4):713-9. PubMed ID: 22291810 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis. Cooper KD; Baadsgaard O; Ellis CN; Duell E; Voorhees JJ J Invest Dermatol; 1990 May; 94(5):649-56. PubMed ID: 2324521 [TBL] [Abstract][Full Text] [Related]
4. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin. Johansen C; Flindt E; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L J Invest Dermatol; 2005 Jun; 124(6):1284-92. PubMed ID: 15955105 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222 [TBL] [Abstract][Full Text] [Related]
6. Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Jiang WY; Chattedee AD; Raychaudhuri SP; Raychaudhuri SK; Farber EM Int J Dermatol; 2001 Nov; 40(11):699-703. PubMed ID: 11737436 [TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between interleukin 6 and interleukin 1 levels in psoriatic lesional skin. Takematsu H; Tagami H Tohoku J Exp Med; 1994 Mar; 172(3):243-52. PubMed ID: 8073436 [TBL] [Abstract][Full Text] [Related]
8. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Otkjaer K; Kragballe K; Funding AT; Clausen JT; Noerby PL; Steiniche T; Iversen L Br J Dermatol; 2005 Nov; 153(5):911-8. PubMed ID: 16225599 [TBL] [Abstract][Full Text] [Related]
9. Increased mRNA expression of manganese superoxide dismutase in psoriasis skin lesions and in cultured human keratinocytes exposed to IL-1 beta and TNF-alpha. Löntz W; Sirsjö A; Liu W; Lindberg M; Rollman O; Törmä H Free Radic Biol Med; 1995 Feb; 18(2):349-55. PubMed ID: 7744320 [TBL] [Abstract][Full Text] [Related]
10. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions. Ohta Y; Katayama I; Funato T; Yokozeki H; Nishiyama S; Hirano T; Kishimoto T; Nishioka K Arch Dermatol Res; 1991; 283(6):351-6. PubMed ID: 1796815 [TBL] [Abstract][Full Text] [Related]
11. Methotrexate, but not narrowband ultraviolet B radiation, suppresses interleukin-33 mRNA levels in psoriatic plaques and protein levels in serum of patients with psoriasis. Meephansan J; Subpayasarn U; Ponnikorn S; Chakkavittumrong P; Juntongjin P; Komine M; Ohtsuki M; Poovorawan Y J Dermatol; 2018 Mar; 45(3):322-325. PubMed ID: 28836690 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 and interleukin-6 in psoriasis. Prens EP; Benne K; van Damme J; Bakkus M; Brakel K; Benner R; van Joost T J Invest Dermatol; 1990 Dec; 95(6 Suppl):121S-124S. PubMed ID: 2258628 [TBL] [Abstract][Full Text] [Related]
13. Role of CYR61 in psoriatic lesional and perilesional skin: A clinical and immunohistochemical study. Shehata WA; Maraee AH; Abdo EE; Hemida AS J Cosmet Dermatol; 2021 Sep; 20(9):2981-2988. PubMed ID: 33484099 [TBL] [Abstract][Full Text] [Related]
14. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Fukuoka M; Ogino Y; Sato H; Ohta T; Komoriya K; Nishioka K; Katayama I Br J Dermatol; 1998 Jan; 138(1):63-70. PubMed ID: 9536224 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration. Witte E; Kokolakis G; Witte K; Warszawska K; Friedrich M; Christou D; Kirsch S; Sterry W; Volk HD; Sabat R; Wolk K J Mol Med (Berl); 2016 Apr; 94(4):391-400. PubMed ID: 26612594 [TBL] [Abstract][Full Text] [Related]
16. Leukocyte infiltration and mRNA expression of IL-20, IL-8 and TNF-R P60 in psoriatic skin is driven by TNF-alpha. Ogilvie AL; Lüftl M; Antoni C; Schuler G; Kalden JR; Lorenz HM Int J Immunopathol Pharmacol; 2006; 19(2):271-8. PubMed ID: 16831294 [TBL] [Abstract][Full Text] [Related]
17. Siramesine causes preferential apoptosis of mast cells in skin biopsies from psoriatic lesions. Hagforsen E; Lampinen M; Paivandy A; Weström S; Velin H; Öberg S; Pejler G; Rollman O Br J Dermatol; 2017 Jul; 177(1):179-187. PubMed ID: 28117878 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708 [TBL] [Abstract][Full Text] [Related]
19. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes. Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488 [TBL] [Abstract][Full Text] [Related]
20. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. Bruch-Gerharz D; Fehsel K; Suschek C; Michel G; Ruzicka T; Kolb-Bachofen V J Exp Med; 1996 Nov; 184(5):2007-12. PubMed ID: 8920887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]